Brief: ISR Enters Into MoU Agreement To Start Vaccine Study In Bangladesh
Aug 6 (Reuters) - ISR Immune System Regulation Holding AB
(publ) ISR.ST :
* ENTERS INTO MOU AGREEMENT TO START VACCINE STUDY IN
BANGLADESH
* SIGNS AGREEMENT WITH BANGLADESH CLINICAL TRIALS LTD
Source text for Eikon: ID:nWkr9LNZJN
Further company coverage: ISR.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent